Medical Marijuana - Medical, Legal, Social and Political Issues
You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.

The Medical Use of Cannabis and Cannabinoids in Huntington's Disease

The endocannabinoid system (ECS) has been intensively researched as a potential therapeutic target in the treatment of Huntington's disease (HD) in pre-clinical cell culture and animal models [1]. Relatively little, however, is known regarding the safety and efficacy of cannabinoid-based therapeutics specifically for HD patients [2]. In this continuing education module, we will describe and discuss the existing clinical literature for cannabinoid-based medicines in HD.

Take a quiz or play a crossword related to this syllabus topic.

This syllabus content additionally qualifies for the following CME designations: Medical Marijuana, Pain Medicine, Palliative Care, Risk Management